{"title":"尼帕病毒附着和融合糖蛋白在进入过程中不同作用的生物物理阐明。","authors":"Sreetama Pal, Hector C. Aguilar, Susan Daniel","doi":"10.1021/acsinfecdis.5c00374","DOIUrl":null,"url":null,"abstract":"<p>Nipah virus (NiV), a World Health Organization priority\r\npathogen,\r\nis a lethal enveloped RNA virus within the <em>Paramyxoviridae</em> family. NiV attachment G and fusion F glycoproteins execute viral-cell\r\nor cell–cell membrane fusion during viral entry and syncytia\r\nformation, respectively. Despite past studies, several aspects of\r\nthe molecular-level orchestration underlying this process, such as\r\nhow F, G, and their interactions regulate fusion, remain poorly understood,\r\nobscured by challenges in decoupling fusion determinants in complex\r\ncellular environments. Here, we report a reconstitution-based approach\r\nfor mimicking the NiV-host interface, employing virus-like particles\r\nwith NiV M, F, and/or G proteins and plasma membrane vesicles derived\r\nfrom NiV-permissive host cells. We found this minimal system can accurately\r\nrecapitulate NiV-host cell fusion, and used this platform for biophysical\r\ndissection of NiV fusion using wild-type or mutant F and G proteins\r\naffecting fusion at distinct intermediate steps. We show that F and\r\nG affect hemifusion and pore formation stages of NiV fusion in distinct\r\nways, revealing a tightly regulated fusion landscape. Our approach\r\nalso delivers one of the first <em>direct</em> measurements\r\nof temperature thresholds for NiV fusion, providing novel insights\r\ninto energetic requirements underlying viral fusogenicity. These findings\r\ndemonstrate the power of this approach in dissecting aspects of NiV\r\nfusion not accessible via cell-based assays. Thus, this study serves\r\nas a blueprint for comprehensive fusion analysis of other viruses\r\nwith multicomponent fusion machinery and host protein receptors, and\r\ncould be repurposed into therapeutic screening platforms targeting\r\ntheir fusion mechanisms, necessary for developing novel antivirals.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"12 8","pages":"2601–2613"},"PeriodicalIF":4.5000,"publicationDate":"2026-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biophysical Elucidation of the Distinct Roles the Nipah Virus Attachment and Fusion Glycoproteins Play in the Entry Process\",\"authors\":\"Sreetama Pal, Hector C. Aguilar, Susan Daniel\",\"doi\":\"10.1021/acsinfecdis.5c00374\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Nipah virus (NiV), a World Health Organization priority\\r\\npathogen,\\r\\nis a lethal enveloped RNA virus within the <em>Paramyxoviridae</em> family. NiV attachment G and fusion F glycoproteins execute viral-cell\\r\\nor cell–cell membrane fusion during viral entry and syncytia\\r\\nformation, respectively. Despite past studies, several aspects of\\r\\nthe molecular-level orchestration underlying this process, such as\\r\\nhow F, G, and their interactions regulate fusion, remain poorly understood,\\r\\nobscured by challenges in decoupling fusion determinants in complex\\r\\ncellular environments. Here, we report a reconstitution-based approach\\r\\nfor mimicking the NiV-host interface, employing virus-like particles\\r\\nwith NiV M, F, and/or G proteins and plasma membrane vesicles derived\\r\\nfrom NiV-permissive host cells. We found this minimal system can accurately\\r\\nrecapitulate NiV-host cell fusion, and used this platform for biophysical\\r\\ndissection of NiV fusion using wild-type or mutant F and G proteins\\r\\naffecting fusion at distinct intermediate steps. We show that F and\\r\\nG affect hemifusion and pore formation stages of NiV fusion in distinct\\r\\nways, revealing a tightly regulated fusion landscape. Our approach\\r\\nalso delivers one of the first <em>direct</em> measurements\\r\\nof temperature thresholds for NiV fusion, providing novel insights\\r\\ninto energetic requirements underlying viral fusogenicity. These findings\\r\\ndemonstrate the power of this approach in dissecting aspects of NiV\\r\\nfusion not accessible via cell-based assays. Thus, this study serves\\r\\nas a blueprint for comprehensive fusion analysis of other viruses\\r\\nwith multicomponent fusion machinery and host protein receptors, and\\r\\ncould be repurposed into therapeutic screening platforms targeting\\r\\ntheir fusion mechanisms, necessary for developing novel antivirals.</p>\",\"PeriodicalId\":17,\"journal\":{\"name\":\"ACS Infectious Diseases\",\"volume\":\"12 8\",\"pages\":\"2601–2613\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2026-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsinfecdis.5c00374\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/7/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsinfecdis.5c00374","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Biophysical Elucidation of the Distinct Roles the Nipah Virus Attachment and Fusion Glycoproteins Play in the Entry Process
Nipah virus (NiV), a World Health Organization priority
pathogen,
is a lethal enveloped RNA virus within the Paramyxoviridae family. NiV attachment G and fusion F glycoproteins execute viral-cell
or cell–cell membrane fusion during viral entry and syncytia
formation, respectively. Despite past studies, several aspects of
the molecular-level orchestration underlying this process, such as
how F, G, and their interactions regulate fusion, remain poorly understood,
obscured by challenges in decoupling fusion determinants in complex
cellular environments. Here, we report a reconstitution-based approach
for mimicking the NiV-host interface, employing virus-like particles
with NiV M, F, and/or G proteins and plasma membrane vesicles derived
from NiV-permissive host cells. We found this minimal system can accurately
recapitulate NiV-host cell fusion, and used this platform for biophysical
dissection of NiV fusion using wild-type or mutant F and G proteins
affecting fusion at distinct intermediate steps. We show that F and
G affect hemifusion and pore formation stages of NiV fusion in distinct
ways, revealing a tightly regulated fusion landscape. Our approach
also delivers one of the first direct measurements
of temperature thresholds for NiV fusion, providing novel insights
into energetic requirements underlying viral fusogenicity. These findings
demonstrate the power of this approach in dissecting aspects of NiV
fusion not accessible via cell-based assays. Thus, this study serves
as a blueprint for comprehensive fusion analysis of other viruses
with multicomponent fusion machinery and host protein receptors, and
could be repurposed into therapeutic screening platforms targeting
their fusion mechanisms, necessary for developing novel antivirals.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.